MENU
PRME
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Prime Medicine (PRME) Ownership - Who owns Prime Medicine?

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing... Show more

Profile

Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
644.42M
P/E Ratio
N/A
Total Cash
213.29M
Projected Growth
N/A
Total Debt
118.14M
Revenue
5.98M
Risk (Beta)
2.86
Dividend Yield
N/A
Total Cash/Share
1.18
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price

Fundamentals

PRME
Capitalization
644M
P/E Ratio
N/A
Risk (Beta)
2.86
Dividend Yield
N/A
Total Cash
213M
Total Cash/Share
1.18
Total Debt
118M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
5.98M
ROE
N/A
Book Value
162M
P/B Ratio
3.98
Cash Flow
N/A
Earnings
-1.42
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
6.61
Current Revenue Per Employee
5724.30
Dividends Per Share - Security
N/A
EBITDA
-196.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-54.98
Shares Held By Institutions
597M
Shares Outstanding - Current
181M
Total Liabilities
223M
Total Volume MTD
N/A
Value
N/A
Gain YTD
22.260
View a ticker or compare two or three
PRME
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRME showed earnings on November 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
21 Erie Street
Phone
+1 617 564-0013
Employees
234
Web
https://www.primemedicine.com